Let's see which of these two names could be best buys. The post Should I buy Fisher & Paykel or ResMed shares? appeared first ...

Leading health technology, Resmed, has announced its home sleep apnea test, NightOwl, is now available across the United ...

NightOwl, an FDA-cleared home sleep apnea test (HSAT) offers a simplified, accurate, efficient way to diagnose obstructive sleep apnea (OSA). It adds another offering to Resmed’s portfolio, which is ...

Three experts explain how obstructive sleep apnea, an often-ignored cardiovascular risk factor, may affect your heart and treatment options.

Health-E Commerce, parent brand to FSA Store and HSA Store, announced today that it has launched a new telehealth collaboration with Daybreak to make sleep apnea testing and treatment available on FSA ...

NightOwl is now widely available across the United States. Individuals interested in NightOwl should speak with their healthcare provider for more information. To learn more, visit: https://www.resmed ...

We came across a bullish thesis on ResMed Inc. (RMD) on Substack by LongTermValue Research. In this article, we will summarize the bulls’ thesis on RMD. ResMed Inc. (RMD)’s share was trading at $223 ...

Among patients with obstructive sleep apnea using CPAP, pitolisant given at 20 mg and 40 mg reduces excessive daytime sleepiness.

Resmed (RMD) announced its home sleep apnea test, NightOwl, is now available across the United States. NightOwl is an FDA-cleared home sleep ...

IHL-42X is designed to treat OSA by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing through the RePOSA Phase ...

Sleep apnea can have untold consequences even in your waking hours. The good news? The condition is treatable.